Cited by 417Fatty Acid Research and HealthAttention Deficit Hyperactivity DisorderAquaculture Nutrition and Growth

Omega-3 fatty acid supplementation for the treatment of children with attention-deficit/hyperactivity disorder symptomatology: systematic review and meta-analysis

Open access
Bloch, Michael H., Qawasmi, Ahmad·2011·Journal of the American Academy of Child & Adolescent Psychiatry

Abstract

Objective Several studies have demonstrated differences in omega-3 fatty acid composition in plasma and in erythrocyte membranes in patients with ADHD compared to unaffected controls. Omega-3 fatty acids have anti-inflammatory properties and can alter central nervous system cell membrane fluidity and phospholipid composition. Cell membrane fluidity can alter serotonin and dopamine neurotransmission. The goal of this meta-analysis is to examine the efficacy of omega-3 fatty acid supplementation in children with ADHD. Method We searched PubMED for randomized, placebo-controlled trials examining omega-3 fatty acid supplementation in children with ADHD symptomatology. Our primary outcome measure was standardized mean difference in rating scales of ADHD severity. We conducted secondary analyses to determine the effects of dosing of different omega-3 fatty acids in supplements. Results Ten trials involving 699 children were included in this meta-analysis. Omega-3 fatty acid supplementation demonstrated a small, but significant effect in improving ADHD symptoms. Eicosapentaenoic acid (EPA) dose within supplements was significantly correlated with supplement efficacy. We found no evidence of publication bias or heterogeneity between trials. Conclusion Omega-3 fatty acid supplementation, particularly with higher doses of EPA, was modestly effective in the treatment of ADHD. The relative efficacy of omega-3 fatty acid supplementation was modest compared to currently available pharmacotherapies for ADHD such as psychostimulants, atomoxetine or alpha-2 agonists. However, given its relatively benign side-effect profile and evidence of modest efficacy, it may be reasonable to use omega-3 fatty supplementation to augment traditional pharmacological interventions or for families who decline other psychopharmacological options.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/j.jaac.2011.06.008

Cites

48 of 48 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Omega-3 fatty acid supplementation was associated with small-to-medium improvements in ADHD symptoms in three meta-analyses.

    “Omega-3 fatty acid supplementation was associated with small-to-medium improvements in ADHD symptoms in three meta-analyses (ten studies with 699 participants, 16 studies with 1,408 participants, 7 studies with 534 participants) (Bloch and Qawasmi, 2011; Chang et al., 2018; Hawkey and Nigg, 2014).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 3

  1. [29]Higgins J Green S Cochrane Handbook for Systematic Reviews of Interventions 4.2.5 2005 John Wiley & Sons, Ltd. Chishester, UK
  2. [33]Deeks J Higgins J Altman D Cochrane Reviewers' Handbook 4.2.1 2003 John Wiley & Sons, Ltd
  3. [34]Brue AW Oakland TD Evans RA The Use of Dietary Supplement Combination and an Essential Fatty Acid as an Alternative and Complementary Treatment for Children with Attention-Deficit/Hyperactivity Disorder Scientific Review of Alternative Medicine 2001 5 187 94

Cited by

Sorted by citations

Authors
Bloch, M. H., & Qawasmi, A.
Affiliations
  • Yale University (US)
  • Al-Quds University (PS)
Corresponding author
Bloch, Michael H.
Venue
Journal of the American Academy of Child & Adolescent Psychiatry
Publisher
Elsevier BV
Published
2011-10
Volume
50
Issue
10
Pages
991-1000
ISSN
0890-8567 (ISSN-L)
OpenAlex
W2016086054
Cited by
417
References
48
Citations by year
2026: 15 · 2025: 15 · 2024: 21 · 2023: 17 · 2022: 15 · 2021: 18 · 2020: 77 · 2019: 26 · 2018: 32 · 2017: 26 · 2016: 36 · 2015: 36 · 2014: 37 · 2013: 25 · 2012: 19
FWCI
3.17
Type
journal article
Language
en
Open access
Locations
  • Journal of the American Academy of Child & Adolescent Psychiatry (publishedVersion)
  • PubMed (publishedVersion)
  • Europe PMC (PubMed Central) (acceptedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Institute of Mental Health (K23MH091240, R25MH077823)
  • National Center for Research Resources (UL1RR024139)
Topics
  • Health Sciences › Nursing › Nutrition and Dietetics › Fatty Acid Research and Health
  • Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
  • Life Sciences › Agricultural and Biological Sciences › Aquatic Science › Aquaculture Nutrition and Growth
Keywords
omega-3 fatty acids, attention deficit hyperactivity disorder, children, eicosapentaenoic acid, dietary supplementation, ADHD symptom severity, cell membrane fluidity, phospholipid composition, non-pharmacological treatment
MeSH terms
Attention Deficit Disorder with Hyperactivity, Child, Humans, Eicosapentaenoic Acid, Fatty Acids, Omega-3

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review